PMC:7299399 / 2450-2858 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T28998","span":{"begin":45,"end":50},"obj":"Body_part"},{"id":"T99009","span":{"begin":78,"end":83},"obj":"Body_part"},{"id":"T5","span":{"begin":301,"end":305},"obj":"Body_part"}],"attributes":[{"id":"A85020","pred":"fma_id","subj":"T28998","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A76501","pred":"fma_id","subj":"T99009","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma74402"}],"text":"riety of molecular mechanisms for entry into cells; long-term survival within cells; and activation, inhibition, or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve the safety of viral "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T27092","span":{"begin":45,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T40144","span":{"begin":78,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T25132","span":{"begin":89,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T36336","span":{"begin":202,"end":207},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T52287","span":{"begin":301,"end":305},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"}],"text":"riety of molecular mechanisms for entry into cells; long-term survival within cells; and activation, inhibition, or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve the safety of viral "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":78,"end":99},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"riety of molecular mechanisms for entry into cells; long-term survival within cells; and activation, inhibition, or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve the safety of viral "}

{"project":"2_test","denotations":[{"id":"32519842-27449616-158444","span":{"begin":174,"end":175},"obj":"27449616"},{"id":"32519842-11642817-158445","span":{"begin":346,"end":347},"obj":"11642817"},{"id":"32519842-32341506-158446","span":{"begin":348,"end":349},"obj":"32341506"}],"text":"riety of molecular mechanisms for entry into cells; long-term survival within cells; and activation, inhibition, or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve the safety of viral "}